Groups | Oocyte nuclear maturation stage | PTX3 mRNA Fold Change | VDR-X2 mRNA Fold Change | |||
---|---|---|---|---|---|---|
PCOS (n = 20) | 1- CCGV-pcos | 0.43 ± 0.07 | 0.68 ± 0.10 | |||
2- CCMI-pcos | 1.29 ± 0.12 | 2.45 ± 0.32 | ||||
3- CCMII-pcos | 1.61 ± 0.31 | 2.87 ± 0.23 | ||||
Normal responders (n = 20) | 4- CCGV-con | 1.00 ± 0.08 | 1.03 ± 0.29 | |||
5- CCMI-con | 3.21 ± 0.32 | 5.63 ± 0.41 | ||||
6- CCMII-con | 9.87 ± 2.38 | 11.51 ± 3.22 | ||||
p-values | p-values | |||||
1 vs. 2 | 0.43 ± 0.07 | 1.29 ± 0.12 | < 0.001 | 0.68 ± 0.10 | 2.45 ± 0.32 | < 0.001 |
1 vs. 3 | 0.43 ± 0.07 | 1.61 ± 0.31 | < 0.001 | 0.68 ± 0.10 | 2.87 ± 0.23 | < 0.001 |
2 vs. 3 | 1.29 ± 0.12 | 1.61 ± 0.31 | 0,075 | 2.45 ± 0.32 | 2.87 ± 0.23 | 0,051 |
4 vs. 5 | 1.00 ± 0.08 | 3.21 ± 0.32 | < 0.002 | 1.03 ± 0.29 | 5.63 ± 0.41 | < 0.007 |
4 vs. 6 | 1.00 ± 0.08 | 9.87 ± 2.38 | < 0.001 | 1.03 ± 0.29 | 11.51 ± 3.22 | < 0.001 |
5 vs. 6 | 3.21 ± 0.32 | 9.87 ± 2.38 | < 0.001 | 5.63 ± 0.41 | 11.51 ± 3.22 | < 0.001 |
3 vs. 6 | 1.61 ± 0.31 | 9.87 ± 2.38 | < 0.001 | 2.87 ± 0.23 | 11.51 ± 3.22 | < 0.001 |